Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma

Bibliographic Details
Title: Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Authors: Villa, Diego *, *, Hoster, Eva *, Hermine, Olivier, Klapper, Wolfram, Szymczyk, Michal, Bosly, André, Unterhalt, Michael, Rimsza, Lisa M., Ramsower, Colleen A., Freeman, Ciara L., Scott, David W., Gerrie, Alina S., Savage, Kerry J., Sehn, Laurie H., Dreyling, Martin
Source: In Blood Advances 27 September 2022 6(18):5285-5294
Database: ScienceDirect
More Details
ISSN:24739529
DOI:10.1182/bloodadvances.2022007371
Published in:Blood Advances
Language:English